Laurus Labs shares rise 3.79% after Q2 profit jumps
In short
Laurus Labs shares rose 3.79% to Rs 2,329 after its Q2FY27 results. Revenue climbed 33% to Rs 2,206 crore, and net profit more than doubled to Rs 441 crore.
This matters because investors are reacting to stronger sales and profits. The report says the growth came from CDMO and Affordable Medicines, but it does not give the company’s full outlook.
What the reporting says
Laurus Labs shares rose 3.79% to Rs 2,329 after the company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while net profit more than doubled to Rs 441 crore. The report says growth came from CDMO and Affordable Medicines, alongside better margins and ongoing manufacturing investment. The immediate market reaction was positive, but the report does not give the full outlook.
Why it matters
Laurus Labs shares gained 3.79% to Rs 2,329 after the company reported strong Q2FY27 results. Revenue rose 33% year-on-year to Rs 2,206 crore and net profit increased to Rs 441 crore. The report ties the improvement to CDMO and Affordable Medicines strength, plus margin gains and investment in manufacturing capacity. It does not state whether this pace can continue.